AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06232473 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Enhanced usual care
Description: Please see arm description
Study NCT05714254 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MEDI0618
Description: Four doses of 100 mg IV, 200 mg IV or 200 mg SC MEDI0618 administered once every two weeks.
Study NCT05714254 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Four doses of IV placebo or SC placebo administered once every two weeks.
Study NCT06355206 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: endoscopic intervention, surgery or conservative treatment
Description: Personal information and treatment of the enrolled subjects will be collected.
Study NCT05707195 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: A questionnaire is offered to parents of patients who meet the eligibility criteria and who have given their non-objection.~This questionnaire aims to evaluate the quality of care perceived by the parents of children hospitalized in the pediatric intensive care unit
Study NCT04752631 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenecteplase
Description: The participants received TNK-tPA thrombolytic therapy
Study NCT02664740 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical anti-Staphylococcus bacteriophage therapy
Description: Patients randomized to the experimental arm will receive sterile compress dressings impregnated with a phage solution of 10\^7 PFU/ml on days 0, 7 and 14 (unless the wound is already healed, i.e. phage solutions are not applied to healed wounds).
Study NCT02664740 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Topical placebo corresponding to anti-Staphylococcus bacteriophage therapy
Description: Patients randomized to the placebo arm will receive sterile compress dressings impregnated with a placebo solution on days 0, 7 and 14 (unless the wound is already healed, i.e. placebo solutions are not applied to healed wounds).
Study NCT05418140 — intervention group
Intervention type: OTHER
Intervention: Ultrasound diagnosis of adenomyosis
Description: The diagnosis of adenomyosis will be made using transvaginal ultrasound scan (TVS) (2D and 3D Ultrasound and applying Morphological Uterus Sonographic Assessment (MUSA) criteria (Van den Bosch et al, 2015).
Study NCT06430736 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tocilizumab before CAR-T cell infusion
Description: Tocilizumab will be given at the standard-dose of 8 mg/kg b.w. intravenously, with completion of the infusion 1 hour prior to infusion of CAR-T cells.~Treatment of eventual subsequent CRS/ICANS will be identical as in patients in the standard arm.
Study NCT06430736 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tocilizumab at emerging CRS
Description: Tocilizumab will be given at the standard-dose of 8 mg/kg b.w. intravenously, and it will be repeated after 8 hours for a maximum of four administrations in patients with ongoing signs of CRS.
Study NCT05725226 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Double J Stent 6Fr x 26cms
Description: Surgery will be performed by expert Urologist.
Study NCT05725226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Double J Stent 4Fr x26cms
Description: Surgery will be performed by expert Urologist.
Study NCT05084638 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ofatumumab
Description: 20mg subcutaneous injection
Study NCT06237660 — intervention group
Intervention type: PROCEDURE
Intervention: Bronchoscopy, with bronchoalveolar lavage and endobronchial biopsy
Description: These children who will be having a bronchoscopy (a long thin tube, with a camera at the end, which is put inside the lung to look at and collect samples) as part of their standard clinical management, determined by their own consultants or treating physicians. They will be having lung samples (washings from the lung and a tiny piece of tissue taken from the breathing tubes) taken as part of their usual medical management. The research team will ask for consent to use the leftover samples for the bronchoscopy, for the study
Study NCT06237660 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Skin prick test
Description: To identify children with allergies. This test will not be done if the child has had allergy testing in the last 6 months
Study NCT06237660 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Finger prick blood test
Description: Finger prick testing will be used for blood samples, and it is the same technique used by children with diabetes, to test their blood sugar levels, and therefore is regularly used in this age group successfully. The research team will be obtain the results within minutes, using a point-of-care device. A few more drops of blood, from the same finger prick sample, will be taken to look at how one of the blood cells work, in more detail, in the laboratory. There is no additional finger prick required for this lab test, and the drops of blood will be collected at the same time, from the same prick, as the point of care test.
Study NCT06243575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Multimodal Intraosseous Femoral Injection
Description: Intraosseous injection of Ketorolac 15mg and Tranexamic acid 500mg in femoral canal
Study NCT06243575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Multimodal Intraosseous Tibial Injection
Description: Intraosseous injection of Ketorolac 15mg and Tranexamic acid 500mg in tibial canal
Study NCT05647837 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: lumper puncture
Description: lumper puncture
Study NCT04079231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brolucizumab
Description: Intravitreal Injection
Study NCT04079231 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept
Description: Intravitreal injection
Study NCT06057974 — intervention group
Intervention type: OTHER
Intervention: Close Collaboration with Parents
Description: The Close Collaboration with Parents intervention is an educational model for healthcare staff working in NICUs. It aims to improve the ability of the members of the NICU healthcare team to I) observe the infants' individual behaviors and needs, II) support parents to take the initiative and share their observations and understanding of their infant's behaviors and to collaboratively plan the infant's care with the healthcare staff, III) understand the individual story of the family regarding parenthood through a dialogue with parents, and IV) involve parents in the decision-making about the care of their baby from an early stage of care through to the preparation for discharge. The final goal is to improve the care culture in the NICUs by changing the attitudes of the healthcare staff and the care practices of the unit to be more in line with family-centered care principles.~It usually takes 1.5 years for each NICU to complete the intervention.
Study NCT06033105 — intervention group
Intervention type: DEVICE
Intervention: ELISA
Description: Enzyme-linked immunosorbent assay (ELISA) was used following manufacturer's instructions. This test uses a competitive ELISA-based technique that was designed to quantitatively determine the concentration of 1,25-dihydroxyvitamin D3/D2 in human serum.
Study NCT06518551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elotuzumab
Description: Humanized, recombinant IgG1 monoclonal antibody, 400- and 300-mg single-use vials, via intravenous (into the vein) infusion per protocol.
Study NCT06518551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iberdomide
Description: A cereblon E3 ligase modulator, 0.15mg, 0.2mg, 0.3mg, 0.45mg, 0.6, and 0.75 mg strength capsule taken orally per protocol.
Study NCT06518551 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Synthetic adrenocortical steroid, 2 and 4 mg tablets, taken orally per standard of care.
Study NCT05299216 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual Diaphragm Technique
Description: Treatment group will receive Manual Diaphragm Technique in addition to Conventional Physical Therapy. Therapist will make physical contact to the underside of the 7th to 10th rib costal cartilages. During the inspiratory phase, the therapist will use both hands to gently pull the points of contact in the direction of the head. During exhalation, the therapist will maintain resistance. The procedure will be done in two sets of ten deep breaths, separated by a one-minute pause.
Study NCT05299216 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy
Description: Conventional Physical Therapy group comprises electrotherapeutic treatment and exercise plan. Subjects will undergo a thermal continuous ultrasound, conventional transcutaneous electrical nerve stimulation and a hot pack.~Stretching activities for the back, iliopsoas, and hamstring muscles, as well as abdominal muscle strengthening exercises, will be included in the workout.
Study NCT05299216 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physical Therapy
Description: Conventional Physical Therapy group comprises electrotherapeutic treatment and exercise plan. Subjects will undergo a thermal continuous ultrasound, conventional transcutaneous electrical nerve stimulation and a hot pack.~Stretching activities for the back, iliopsoas, and hamstring muscles, as well as abdominal muscle strengthening exercises, will be included in the workout.
Study NCT05299216 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sham Diaphragm Manual Technique
Description: The Control group will also receive a sham diaphragm release technique. The therapist and participant will have the same manual contacts, duration, and placement as the treatment group, but the therapist will simply use a light touch with the same anatomical landmarks and will not apply pressure.
Study NCT05051722 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tampon Collection
Description: A tampon will be self-inserted by each participant prior to any exams or procedures and removed after 40 minutes..
Study NCT05051722 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Collection
Description: A blood sample will be collected from each participant prior to undergoing any exams or procedures.
Study NCT06314659 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Zhifei Lvzhu)
Description: Performed primary immunization following a 0-1-2-month schedule at the aged from 3 to 5 months and booster immunization at 18 months of age.
Study NCT06314659 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Zhifei Lvzhu)
Description: Performed primary immunization following a 0-1-2-month schedule at the aged from 3 to 5 months and booster immunization at 18 months of age.
Study NCT06314659 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Walvax)
Description: Performed primary immunization following a 0-1-2-month schedule at the aged from 3 to 5 months.
Study NCT06314659 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Group A and C Meningococcal Polysaccharide Conjugate Vaccine (producted by Olymvax)
Description: Performed booster immunization at 18 months of age.
Study NCT04802031 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rapid Infusion Isatuximab
Description: Given IV
Study NCT05558137 — intervention group
Intervention type: DRUG
Intervention: Mivacurium
Description: 0.2 mg/kg based on ideal body weight calculated as height (cm) minus 105 for women and height (cm) minus 100 for men or actual body weight, whichever is lower
Study NCT05631340 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discharge education
Description: Researcher's newly prepared discharge education supported by a booklet and mobile app
Study NCT05631340 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Discharge education
Description: Researcher's newly prepared discharge education supported by a booklet and mobile app
Study NCT04114708 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Anterior cruciate ligament Reconstruction (ACLR)
Description: All patients will undergo an anatomic ACLR via a standardized fashion using BTB autograft.
Study NCT04114708 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ACLR with lateral extra-articular tenodesis (LET)
Description: All LETs will be performed in a standardized fashion using the modified Lameire technique. All patients will undergo an anatomic ACLR via a standardized fashion using BTB autogaft graft.
Study NCT05260476 — intervention group
Intervention type: OTHER
Intervention: Reablement
Description: The service provider customizes a training plan and formulates training goals based on the patient's level of disability, family environment, and the needs of the patient and the caregiver.
Study NCT05747014 — intervention group
Intervention type: DEVICE
Intervention: Novapak Nasal Sinus Packing and Stent
Description: Potential subjects will have the need to undergo nasal/sinus surgery using a space-occupying stent and will perform daily self-saline nasal irrigations.
Study NCT04626037 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WECS Relational Toolkit
Description: The Cuddle and Calm Book, The Mommy Baby Book, mother and child mutual narrative, the Bottle of Emotions, and the WECS for emotional connection, make up the WECS Relational Health toolkit.
Study NCT05242562 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plenvu
Description: a recently developed 1 liter bowel preparation fluid that is often used in clinical practice. Patients will receive a split dose protocol, low-residue diet 2 days before colonoscopy, and clear liquid diet 1 day before colonoscopy.
Study NCT05242562 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moviprep
Description: a 2 liter widely established 2 liter bowel preparation fluid that is commonly used in clinical practice. Patients will receive a split dose protocol, low-residue diet 2 days before colonoscopy, and clear liquid diet 1 day before colonoscopy.
Study NCT04926597 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: nutritional supplement
Description: daily use of one or more specific oral nutritional supplement with high energy/protein content (i.e., Resource Ultra, Resource 2.0 (Fibre), Resource Ultra Fruit).
Study NCT04926597 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: individualized nutritional guidelines
Description: nutritional plan supervised by an experienced study dietician based on the usual home nutrition with possibility to increase intake by adaptation to patient preferences, between meal snaking and food enrichment/fortification. Every 2-4 weeks phone call by unblinded study dietician to follow nutritional intervention.
Study NCT04926597 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: general nutritional information
Description: general information about health food behavior upon hospital discharge
Study NCT05286788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Binimetinib Oral Tablet [Mektovi]
Description: Binimetinib oral continuous dosing 32 mg/m2 PO BID for 4 weeks
Study NCT04594317 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: low level laser therapy
Description: buccal application of diode laser on non-contact mode
Study NCT04594317 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low level laser therapy
Description: buccal application of diode laser on non-contact mode
Study NCT04714827 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: KQ-2003 CAR-T cells
Description: A autologous doping CAR - T cells injection targets with CD19 and BCMA，fluorine dara marina injection(30 mg/m2，QD×3d) and cyclophosphamide injection (300 mg/m2，QD×3d)will be used to remove the lymphocyte before infusion KQ-2003 CAR-T cells .
Study NCT06026540 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pilates Exercise
Description: After the first measurements were made and the groups were determined; Students in the experimental group will be given pilates exercises 2 days a week for 6 months. Pilates mat, pilates circle, tiny pilates ball and pilates band will be used during the pilates exercise. The duration of the Pilates exercise is 30 minutes in total, and the peer-guided application via Zoom includes the following order:~Stretching 5 minutes, superman 1 minute, quodratus stretch 2 minutes, marble 1 minute, half plank kick 4 minutes, side kick 4 minutes, pelvic curl 2 minutes, cat pose 1 minute, spine stretch 2 minutes, one leg circle 3 minutes, side leg lift 3 minutes, single leg kick 2 minutes.
Study NCT06020391 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaborative drug review
Description: 1. Structured, clinical drug review including medical history, physical examination, and supplementary tests. The work-up will be aimed at evaluating whether current medications are indicated, whether the patient's medical conditions are satisfactorily compensated, whether dosages are appropriate, whether the patient has adverse drug effects, and whether drug-drug or drug-disease interactions are present or likely to occur. The MipAC physicians will receive clinical supervision from a consultant in geriatric medicine.~2. The MipAC physician will offer the patient's FP a telephone meeting with the purpose of combining the assessments of the MipAC physician and the competence of the FP in a common drug review. The two physicians will review the patient's drug list systematically and discuss if any adjustments should be done, as well as the patient's need for further follow-up.
Study NCT04891718 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MVC-101
Description: Intratumoural microdose injection by the CIVO device.
Study NCT04891718 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Intratumoural microdose injection by the CIVO device.
Study NCT04891718 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MVC-101 + Nivolumab
Description: Intratumoural microdose injection by the CIVO device.
Study NCT05170958 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBL-024 for Injection
Description: LBL-024 was given every three weeks for treatment
Study NCT04887168 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Survive & Thrive
Description: Psychoeducational Intervention: Survive \& Thrive (Ferguson, 2008; Mahoney et al, 2018). A total of 10 manualised sessions of approximately 1.5 hour duration are offered. Individual sessions run using an educational format and in an informal setting, with a strong emphasis on avoiding individual disclosures. Groups will be delivered utilising a multi-disciplinary work force consisting of mental health staff in a ratio of 2 per group. Groups will consist of a maximum of 8-10 participants
Study NCT05728424 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vonoprazan, Amoxicillin, Levofloxacin
Description: No additional information
Study NCT05728424 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vonoprazan, Amoxicillin, Levofloxacin
Description: No additional information
Study NCT05544214 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-371
Description: PO
Study NCT06124495 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
Description: The subjects randomly received single oral dose of Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet (Test or reference)
Study NCT04946682 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Types of etiological diagnostic methods
Description: In Group of mNGS, all patients will be tested by meta next generation sequncing on admission, while patients in Group of PCR will be tested by polymerase chain reaction in accordance with the method in the guidelines.
Study NCT05906485 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: fNIRS Neurofeedback-VR Training
Description: In the fNIRS Neurofeedback-VR Training, we have designed a classroom scenario modeled and children are expected to learn how to regulate their attention based on the feedback provided by the fNIRS on the oxygenated haemoglobin level in their prefrontal cortex.
Study NCT05906485 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: fNIRS Neurofeedback-VR Training
Description: In the fNIRS Neurofeedback-VR Training, we have designed a classroom scenario modeled and children are expected to learn how to regulate their attention based on the feedback provided by the fNIRS on the oxygenated haemoglobin level in their prefrontal cortex.
Study NCT05906485 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Computerized Cognitive Training
Description: In the Computerized Cognitive Training, children will complete a range of tasks covering attention control and working memory using a conventional training programme, namely Cogmed.
Study NCT05906485 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Computerized Cognitive Training
Description: In the Computerized Cognitive Training, children will complete a range of tasks covering attention control and working memory using a conventional training programme, namely Cogmed.
Study NCT06354920 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bonding Bundle
Description: Doctors in the intervention arm will be asked to use suggested approaches while meeting with their hospitalized patients. The goal of these strategies is to improve the relationship and interactions between patients and physicians.